Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?

Eur Respir J. 2020 Jan 30;55(1):1902028. doi: 10.1183/13993003.02028-2019. Print 2020 Jan.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • Cardiology*
  • Humans
  • Pulmonary Embolism*
  • Risk Factors

Substances

  • Anticoagulants